Showing results (141-150 of 1,043) with videos related to
Sort By:
Pageof 105
Journal of Biomechanics|June 1, 1992
Ice friction during speed skatingJ J de Koning, G de Groot, G J van Ingen SchenauThe Journal of Pathology|February 1, 1995
High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatmentE J de Koning, K A Fleming, D W Gray, et al.Nederlands Tijdschrift Voor Geneeskunde|August 30, 2008
[Umbilical cord blood from an unrelated donor as source for stem cell transplantations in inborn errors of metabolism]M Aldenhoven, T J de Koning, N M Wulffraat, et al.British Journal of Haematology|February 1, 1984
The HLA-system in immune thrombocytopenic purpura: its relation to the outcome of therapyJ W Gratama, J D'Amaro, J de Koning, et al.Revue Neurologique|August 27, 2016
Neurometabolic disorders are treatable causes of dystoniaA Kuiper, H Eggink, M A J Tijssen, et al.International Journal of Cancer|August 16, 2014
Screening for prostate cancer in the US? Reduce the harms and keep the benefitTiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de KoningBJU International|May 26, 2016
Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation studyTiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de KoningAnnals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|July 3, 2013
Screening for type 2 diabetes in a high-risk population: effects of a negative screening test after 4 years follow-upJulie I Willems, Suzie J Otto, Bart Klijs, et al.Scandinavian Journal of Haematology|January 1, 1984
Long-term follow-up study of 168 patients with immune thrombocytopenia. Implications for therapyG J den Ottolander, J W Gratama, J de Koning, et al.Cancer|December 13, 2017
Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillanceTiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de KoningPageof 105